about
Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for InstitutesAcinetobacter baumannii : Role in Blood Stream Infection in Neonatal Unit, Dr. Cipto Mangunkusumo Hospital, Jakarta, IndonesiaAttributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii.Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.Detection of KPC in Acinetobacter spp. in Puerto Rico.Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control programDissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo MadagascarGenome Sequence of an Extremely Drug-Resistant Clinical Isolate of Acinetobacter baumannii Strain AB030.Genome Sequence of a Tigecycline-Resistant Clinical Isolate of Acinetobacter baumannii Strain AB031 Obtained from a Bloodstream Infection.Overview of nosocomial infections caused by gram-negative bacilli.Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period.Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.Drug treatment for multidrug-resistant Acinetobacter baumannii infections.Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit.Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study.Acinetobacter baumannii: emergence of a successful pathogenPiscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse modelPoly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.Variability in gene cassette patterns of class 1 and 2 integrons associated with multi drug resistance patterns in Staphylococcus aureus clinical isolates in Tehran-IranSurveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.Flammability testing of 22 conventional European pediculicides.The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit.Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature.Draft Genome Sequences of Two Extensively Drug-Resistant Acinetobacter baumannii Strains Isolated from Pus SamplesClinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.Treatment options for multidrug-resistant Acinetobacter species.Early detection of nosocomial outbreaks caused by rare pathogens: a case study employing score prediction interval.Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125Acinetobacter baumannii: an emerging multidrug-resistant threat.Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.Role of matching in case-control studies of antimicrobial resistance.Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.Multi-drug resistant Acinetobacter species from various clinical samples in a tertiary care hospital from South India.Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.
P2860
Q26799202-8C99FE2A-5A31-4004-B8A0-0E254843044FQ29041602-C9326891-A87C-44F8-82FB-6AE93EFF6251Q33237577-304AB400-4FC2-41CE-9C74-252229BDC4DEQ33425665-6E3BF7EB-826C-4F8A-9611-5F31C576D293Q33549724-CCCAF086-78E9-4D5C-A200-71EFF76EDD9FQ33608336-876176B0-9D32-42CB-986B-B2728FCFA5B3Q33676198-FEB17C14-A186-4D72-84BD-FDD18EDB7D43Q33935406-9A669743-9DBE-4E7F-BC79-7E6DFB1F86E7Q34020061-5E48F92B-768D-4B72-AAC9-F046D3CE5E6CQ34355001-2F01EDCB-6A9F-45E8-8E3C-403F318A171AQ34355009-13F79B68-BED2-4BED-BD34-9CDE15206F6BQ34444001-DEE1CD08-048A-4CEA-9A0C-6E9AA1A95A98Q34489499-AEE5895B-C585-4CCB-9C46-79F2F6A1EDDEQ34568784-AED73EE2-4A0C-4600-9820-4EAB03F611D3Q34601684-D2EA2538-441F-4CB2-986E-ACAE8C6C58ACQ34612269-EE456716-9569-4043-8760-C9D4E4898340Q34676586-376394CF-7AD1-4375-B054-070E168F45E8Q34795807-0B9AC2D2-958D-485C-9C49-FA409822D755Q35548903-0911770D-9BF9-4180-95A8-663829DA76B2Q35689459-FB36A663-D43D-4654-9431-DFB2D174815CQ35728757-767E7852-45D9-4112-AD32-432F9F948AA7Q35784520-33233E72-C0D5-4A53-8391-D0A82C570C6CQ36013063-DE58FC5D-54E3-48AF-A59B-8A96EFF9A5E9Q36150941-24F869F9-5D23-4567-B995-1C354DCB7792Q36268549-32FA5D15-4372-447E-988A-884FF11E6C00Q36292258-4BB38771-B645-493F-B8A8-872FD4839D56Q36633704-901240F8-74F1-4840-AC60-27064B1E52D5Q36664072-8271E78D-9111-4788-B539-B952A6D9A491Q36727292-D025CFCB-80EE-4973-82E4-D62505B20720Q36887794-82F9E3F7-449E-4F61-916D-005CB92A58EBQ37058001-1AF99F89-A52B-4F97-BC9A-89131A5636F8Q37083127-518E5350-76B8-4940-83FB-50045205034FQ37156759-81EE7430-2E11-40C2-B976-AA90695BDDB8Q37202840-943DEB8A-BCD9-4A78-AFBA-F70F7FFB50BAQ37205116-AB291318-BC17-466A-AFDC-D6885E39F205Q37220041-C0381544-B508-4FEF-8C6C-C5D463F44905Q37399052-2841D020-C717-4F30-8CE4-9D0A42B30AABQ37413428-C493597C-2F86-47BD-A19A-88FA8599ABC5Q37424864-500893AD-1E11-4FB1-AA61-F54772C2DB8BQ37439554-2D9ABC87-3F65-4879-B551-FFCB54D55D26
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multidrug-resistant Acinetobacter baumannii
@ast
Multidrug-resistant Acinetobacter baumannii
@en
Multidrug-resistant Acinetobacter baumannii
@nl
type
label
Multidrug-resistant Acinetobacter baumannii
@ast
Multidrug-resistant Acinetobacter baumannii
@en
Multidrug-resistant Acinetobacter baumannii
@nl
prefLabel
Multidrug-resistant Acinetobacter baumannii
@ast
Multidrug-resistant Acinetobacter baumannii
@en
Multidrug-resistant Acinetobacter baumannii
@nl
P2093
P2860
P921
P3181
P356
P1476
Multidrug-resistant Acinetobacter baumannii
@en
P2093
Aharon Abbo
Orly Hammer-Muntz
Tami Krichali
Yardena Siegman-Igra
Yehuda Carmeli
P2860
P3181
P356
10.3201/EID1101.040001
P407
P577
2005-01-01T00:00:00Z